GSK and Verily Life Sciences(formerly Google Life Sciences) recently announced the creation of Galvani Bioelectronics which will realize the dream of creating bioelectronic therapeutics, truly ushering in the era of AI in human health solutions. At a cumulative investment of over US $ 700 million, this is a proverbial moon shot with an exciting array… Continue reading The perfect marriage of technology and therapeutics